Linagliptin is an oral medication used to treat DMT2. It is generally less preferred than metformin and sulfonylureas as an initial treatment. It is used together with exercise and diet. It is not recommended in DMT1
Common side effects include inflammation of the nose and throat. Serious side effects may include angioedema, pancreatitis, joint pain.
Use in pregnancy and breastfeeding is not recommended. Linagliptin is a dipeptidyl peptidase-4 inhibitor. It works by increasing the production of insulin and decreasing the production of glucagon by the pancreas.
Synonyms
Trajenta